Erratum: Suppression of pancreatic tumor growth by combination chemotherapy with sulindac and LC-1 is associated with cyclin D1 inhibition in vivo (Molecular Cancer Therapeutics (2007) 6, (1736-1744))

M. T. Yip-Schneider, H. Wu, M. Ralstin, C. Yiannoutsos, P. A. Crooks, S. Neelakantan, S. Noble, H. Nakshatri, C. J. Sweeney, C. M. Schmidt

Research output: Contribution to journalComment/debate

Original languageEnglish (US)
Number of pages1
JournalMolecular cancer therapeutics
Volume6
Issue number10
DOIs
StatePublished - Oct 1 2007

Fingerprint

Sulindac
Cyclin D1
Combination Drug Therapy
Growth
Neoplasms
Therapeutics

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

@article{717d5b33e52e451cb677ad4628626a04,
title = "Erratum: Suppression of pancreatic tumor growth by combination chemotherapy with sulindac and LC-1 is associated with cyclin D1 inhibition in vivo (Molecular Cancer Therapeutics (2007) 6, (1736-1744))",
author = "Yip-Schneider, {M. T.} and H. Wu and M. Ralstin and C. Yiannoutsos and Crooks, {P. A.} and S. Neelakantan and S. Noble and H. Nakshatri and Sweeney, {C. J.} and Schmidt, {C. M.}",
year = "2007",
month = "10",
day = "1",
doi = "10.1158/1535-7163.MCT-06-10-COR",
language = "English (US)",
volume = "6",
journal = "Molecular Cancer Therapeutics",
issn = "1535-7163",
publisher = "American Association for Cancer Research Inc.",
number = "10",

}

TY - JOUR

T1 - Erratum

T2 - Suppression of pancreatic tumor growth by combination chemotherapy with sulindac and LC-1 is associated with cyclin D1 inhibition in vivo (Molecular Cancer Therapeutics (2007) 6, (1736-1744))

AU - Yip-Schneider, M. T.

AU - Wu, H.

AU - Ralstin, M.

AU - Yiannoutsos, C.

AU - Crooks, P. A.

AU - Neelakantan, S.

AU - Noble, S.

AU - Nakshatri, H.

AU - Sweeney, C. J.

AU - Schmidt, C. M.

PY - 2007/10/1

Y1 - 2007/10/1

UR - http://www.scopus.com/inward/record.url?scp=35848929288&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=35848929288&partnerID=8YFLogxK

U2 - 10.1158/1535-7163.MCT-06-10-COR

DO - 10.1158/1535-7163.MCT-06-10-COR

M3 - Comment/debate

AN - SCOPUS:35848929288

VL - 6

JO - Molecular Cancer Therapeutics

JF - Molecular Cancer Therapeutics

SN - 1535-7163

IS - 10

ER -